UNICREDIT BANK/CALL/MERCK/210/0.1/18.12.24 Share Price

Warrant

DE000HC6D795

Market Closed - BOERSE MUENCHEN 20:41:24 24/05/2024 BST
0.28 EUR -6.67% Intraday chart for UNICREDIT BANK/CALL/MERCK/210/0.1/18.12.24
Current month+154.55%
1 month+115.38%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24/05/24 0.28 -6.67%
23/05/24 0.3 +11.11%
22/05/24 0.27 +17.39%
21/05/24 0.23 0.00%
20/05/24 0.23 -8.00%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 08:41 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HC6D79
ISINDE000HC6D795
Date issued 02/05/2023
Strike 210
Maturity 18/12/2024 (207 Days)
Parity 10 : 1
Emission price 1.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.18
Lowest since issue 0.096
Spread 0.05
Spread %16.13%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.8 EUR
Average target price
182.9 EUR
Spread / Average Target
+9.05%
Consensus